Sangamo Therapeutics Inc. buy Wells Fargo & Company
Start price
10.08.23
/
50%
€0.99
Target price
10.08.24
€3.63
Performance (%)
-63.03%
Price
19.07.24
€0.37
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Sangamo Therapeutics Inc. is performing very badly with a performance of -63.03%. This prediction currently runs until 10.08.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sangamo Therapeutics Inc. | -12.188% | -12.188% |
iShares Core DAX® | -3.033% | 0.651% |
iShares Nasdaq 100 | -3.554% | -3.007% |
iShares Nikkei 225® | -3.938% | 1.935% |
iShares S&P 500 | -1.517% | -0.602% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Wells Fargo & Company from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat